ipilimumab nivolumab melanoma trial

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
ipilimumab nivolumab melanoma trial	0.99	0.2	6853	100	35
ipilimumab	1.6	0.1	6544	3	10
nivolumab	1.34	0.8	8678	9	9
melanoma	1.75	0.6	113	65	8
trial	1.11	0.6	3986	69	5

Keyword	CPC	PCC	Volume	Score
ipilimumab nivolumab melanoma trial	0.6	0.3	913	60
ipilimumab and nivolumab metastatic melanoma	0.41	0.3	6027	57
nivolumab plus ipilimumab melanoma	0.43	0.6	8896	82
ipilimumab and nivolumab immunotherapy	1.68	0.3	1969	45
nivolumab and ipilimumab therapy	1.09	0.5	8437	82
nice ipilimumab nivolumab melanoma	0.38	0.4	2970	98
ipilimumab + nivolumab	0.59	0.3	421	100
nivolumab immunotherapy for melanoma	1.72	1	2998	84
ipilimumab and nivolumab patient information	1.43	0.2	4069	56
nivolumab combined with ipilimumab	1.43	0.1	7163	99
ipilimumab and nivolumab macmillan	0.65	0.8	3227	10
ipilimumab nivolumab combination fda approval	0.48	0.1	7062	4
ipilimumab nivolumab colon cancer	0.83	0.4	4553	4
ipilimumab and nivolumab protocol	1.31	0.4	9728	84